Opendata, web and dolomites

JPCOFUND2 SIGNED

ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 JPCOFUND2 project word cloud

Explore the words cloud of the JPCOFUND2 project. It provides you a very rough idea of what is the project "JPCOFUND2" about.

platforms    proposals    supportive    defragmentation    jpnd    coming    infrastructure    participating    alignment    aligning    discovery    132m    actions    disease    neurodegeneration    47    tackling    million    2011    jpi    databases    interoperable    explored    medicine    collaborative    patients    building    accelerate    strategies    ec    2019    created    training    progression    countries    nearly    co    highest    prevention    platform    carers    establishing    education    lacking    almost    enhanced    jpcofund    neurodegenerative    living    capacity    society    benefits    scaling    synergies    people    stop    competitive    national    global    continue    expand    consolidate    amongst    area    personalised    horizon    efforts    treatments    parallel    cumulated    care    launching    double    dementia    grand    capacities    funds    24    transnational    links    diagnosis    prevent    worldwide    reference    strategy    earmarked    innovation    accessible    pilot    2020    calls    diseases    successes    earlier   

Project "JPCOFUND2" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 33˙438˙899 €
 EC max contribution 11˙010˙911 € (33%)
 Programme 1. H2020-EU.3.1.1. (Understanding health, wellbeing and disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme ERA-NET-Cofund
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 59˙812.00
2    DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV DE (KOELN) participant 2˙486˙611.00
3    MINISTERO DELLA SALUTE IT (ROMA) participant 880˙707.00
4    NORGES FORSKNINGSRAD NO (OSLO) participant 844˙820.00
5    UNITED KINGDOM RESEARCH AND INNOVATION UK (SWINDON) participant 844˙820.00
6    AGENCE NATIONALE DE LA RECHERCHE FR (PARIS) participant 639˙596.00
7    SCHWEIZERISCHER NATIONALFONDS ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG CH (Bern) participant 516˙462.00
8    MINISTRY OF EDUCATION YOUTH AND SPORTS CZ (Prague) participant 434˙372.00
9    VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL SE (STOCKHOLM) participant 434˙372.00
10    ZORGONDERZOEK NEDERLAND ZON NL (DEN HAAG) participant 434˙372.00
11    Ministrstvo za izobrazevanje, znanost in sport SI (Ljubljana) participant 318˙394.00
12    FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN BE (BRUSSEL) participant 311˙238.00
13    SUOMEN AKATEMIA FI (HELSINKI) participant 270˙193.00
14    INNOVATIONSFONDEN DK (KOBENHAVN K) participant 265˙036.00
15    INSTITUTO DE SALUD CARLOS III ES (MADRID) participant 265˙036.00
16    NARODOWE CENTRUM NAUKI PL (KRAKOW) participant 229˙149.00
17    MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA IT (ROMA) participant 223˙991.00
18    OSTERREICHISCHE FORSCHUNGSFORDERUNGSGESELLSCHAFT MBH AT (WIEN) participant 217˙186.00
19    TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU TR (ANKARA) participant 208˙626.00
20    FONDS NATIONAL DE LA RECHERCHE LU (ESCH-SUR-ALZETTE) participant 188˙103.00
21    THE HEALTH RESEARCH BOARD IE (DUBLIN) participant 175˙790.00
22    FUNDACAO PARA A CIENCIA E A TECNOLOGIA PT (LISBOA) participant 147˙059.00
23    NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL HU (BUDAPEST) participant 147˙059.00
24    VALSTS IZGLITIBAS ATTISTIBAS AGENTURA LV (RIGA) participant 147˙059.00
25    MINISTRY OF HEALTH IL (JERUSALEM) participant 126˙126.00
26    FONDS DE LA RECHERCHE SCIENTIFIQUE- FNRS BE (BRUXELLES) participant 106˙014.00
27    FUNDO REGIONAL PARA A CIENCIA E TECNOLOGIA PT (PONTA DELGADA) participant 64˙969.00
28    FONDATION DE COOPERATION SCIENTIFIQUE MALADIE D'ALZHEIMER ET MALADIES APPARENTEES FR (PARIS) participant 23˙925.00
29    CANADIAN INSTITUTES OF HEALTH RESEARCH CA (OTTAWA ONTARIO) participant 0.00

Map

 Project objective

Worldwide, nearly 47 million people are currently estimated to be living with dementia, and the number is expected to almost double every 20 years, yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 30 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND has a long standing experience in collaborative actions; since 2011, a cumulated funding of 132M€ has been dedicated to competitive transnational calls and JPND is now a reference for European and global knowledge and as an innovation platform in the area of neurodegenerative diseases. Building on earlier successes of the JPND Research Strategy in scaling-up and establishing synergies with Horizon 2020, there is a need to continue previous efforts to consolidate the JPND successes in defragmentation, better coordination and alignment amongst the countries, by developing new links with the EC. JPcofuND 2 aims at launching in 2019 an ambitious call for proposals on personalised medicine, where the benefits for the patients affected with neurodegenerative diseases will be explored through personalised diagnosis, personalised prevention and personalised care. Participating countries have earmarked 24,7 M€ of national funds for this call. Moreover, to expand the impact of the project, JPND will continue to implement other actions without EU co-funding such as aligning national research strategies, making databases more accessible and interoperable, developing enabling capacities such as supportive infrastructure and platforms, capacity building, education and training. These actions are required in parallel to achieve the highest impact for the patients, their carers and for society as whole and address this grand challenge in the coming years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "JPCOFUND2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "JPCOFUND2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.1.)

ARREST-TB (2019)

Accurate, Rapid, Robust and Economical diagnostic technoliogieS for Tuberculosis

Read More  

BIND (2020)

Brain Involvement iN Dystrophinopathies

Read More  

BRAINTIME (2020)

Molecular atlas of the brain across the human lifespan

Read More